Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls

Autor: Wen-Xing Ding, Hartmut Jaeschke, David S Umbaugh, Olamide B. Adelusi, Giselle Sanchez-Guerrero, Nga T. Nguyen, Jephte Y. Akakpo, Anup Ramachandran
Rok vydání: 2021
Předmět:
GSSG
glutathione disulfide

LOOH
lipid hydroperoxides

NQO1
NAD(P)H:quinone oxidoreductase 1

TLR
toll like receptor

HNE
4-hydroxynonenal

NAC
N-acetylcysteine

Apoptosis
Review
Bioinformatics
SMAC/DIABLO
second mitochondria-derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pI

GSH
glutathione

General Pharmacology
Toxicology and Pharmaceutics

Liver injury
Innate immunity
BSO
buthionine sulfoximine

mTORC1
mammalian target of rapamycin complex 1

MCP-1
monocyte chemoattractant protein-1

Mitochondria
CYP
cytochrome P450 enzymes

GPX4
glutathione peroxidase 4

NRF2
nuclear factor erythroid 2-related factor 2

KEAP1
Kelch-like ECH-associated protein 1

LPO
lipid peroxidation

NF-κB
nuclear factor κB

medicine.drug
DMSO
dimethylsulfoxide

Inflammatory response
Gclm
glutamate–cysteine ligase modifier subunit

HMGB1
high mobility group box protein 1

APAP
acetaminophen

ARE
antioxidant response element

RM1-950
TUNEL
terminal deoxynucleotidyl transferase dUTP nick end labeling

UGT
UDP-glucuronosyltransferases

Necrotic cell
MPT
mitochondrial permeability transition

Acetaminophen hepatotoxicity
NRF2
ROS
reactive oxygen species

EndoG
endonuclease G

medicine
Autophagy
Injury mechanisms
Ferroptosis
MnSOD
manganese superoxide dismutase

Antipyretic drugs
MDA
malondialdehyde

Drug metabolism
business.industry
ATG
autophagy-related genes

PUFAs
polyunsaturated fatty acids

Liver failure
medicine.disease
CAD
caspase-activated DNase

Gclc
glutamate–cysteine ligase catalytic subunit

Acetaminophen
LC3
light chain 3

AIF
apoptosis-inducing factor

AMPK
AMP-activated protein kinase

DAMPs
damage-associated molecular patterns

JNK
c-jun N-terminal kinase

Therapeutics. Pharmacology
LAMP
lysosomal-associated membrane protein

business
NAPQI
N-acetyl-p-benzoquinone imine

FSP1
ferroptosis suppressing protein 1

MAP kinase
mitogen activated protein kinase
Zdroj: Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 12, Pp 3740-3755 (2021)
ISSN: 2211-3835
Popis: Acetaminophen (APAP) is a widely used analgesic and antipyretic drug, which is safe at therapeutic doses but can cause severe liver injury and even liver failure after overdoses. The mouse model of APAP hepatotoxicity recapitulates closely the human pathophysiology. As a result, this clinically relevant model is frequently used to study mechanisms of drug-induced liver injury and even more so to test potential therapeutic interventions. However, the complexity of the model requires a thorough understanding of the pathophysiology to obtain valid results and mechanistic information that is translatable to the clinic. However, many studies using this model are flawed, which jeopardizes the scientific and clinical relevance. The purpose of this review is to provide a framework of the model where mechanistically sound and clinically relevant data can be obtained. The discussion provides insight into the injury mechanisms and how to study it including the critical roles of drug metabolism, mitochondrial dysfunction, necrotic cell death, autophagy and the sterile inflammatory response. In addition, the most frequently made mistakes when using this model are discussed. Thus, considering these recommendations when studying APAP hepatotoxicity will facilitate the discovery of more clinically relevant interventions.
Graphical abstract This review discusses common pitfalls in studies of acetaminophen hepatotoxicity.Image 1
Databáze: OpenAIRE